ViiV Healthcare's two-drug HIV pill Dovato (dolutegravir/lamivudine) has matched the efficacy of Gilead's market-leading ...

UK pharma major GSK reported better-than-expected second-quarter 2026 results, helped by continued growth in Specialty ...

US obesity specialist Ambrosia Biosciences has strengthened its clinical and scientific ranks, naming cardiometabolic drug ...

US biotech Apnimed has set the terms for its long-awaited initial public offering, seeking to raise up to $150 million as it prepares for a potential commercial launch of its lead obstructive sleep ...

Positive high-level results from the CLARITY-Gastric01 global Phase III trial showed that sonesitatug vedotin (Sone-Ve) ...

Cambridge, USA-based biotech Oak Hill Bio this morning announced plans to go public via a combination with RA Capital-backed ...

Shares of US biotech Forte Biosciences shot up nearly 40% to $76.40 in early trading, on the news of a takeover bid from ...

US biotech Outlook Therapeutics revealed that the US Food and Drug Administration (FDA) has approved Lytenava ...

UK-based Novogene Europe, a multiomics research services partner, today announced that it has expanded its single-cell RNA ...

Among significant news last week, Halozyme Therapeutics struck a license agreement for its INCA033989 with fellow USA-based ...

Swiss contract development and manufacturing group Lonza today reported sales of 3.4 billion francs ($4.25 billion) in the ...

Sanofi has announced changes to its executive committee, as the French pharma major streamlines senior leadership under chief ...